DCF — HOLLYWOOD PRESBYTERIAN MEDICAL CNTR
Enterprise Value: $-292.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-292.7M
Enterprise Value
$-101.9M
PV of Cash Flows
$-190.8M
PV of Terminal Value
$-307.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $459.7M | $-13.2M | -3.0% | $-32.6M | $-29.7M |
| Year 2 | $473.5M | $-8.8M | -2.0% | $-28.9M | $-23.9M |
| Year 3 | $487.7M | $-4.2M | -1.0% | $-24.8M | $-18.7M |
| Year 4 | $502.3M | $-1.8M | -0.0% | $-23.1M | $-15.8M |
| Year 5 | $517.4M | $-0.6M | -0.0% | $-22.5M | $-14.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-292.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$446.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.0336212003126634
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5